William S. Weintraub, MD, FACC

Commentary

The Evolving Role for a Left Ventricular Assist Device in High-Risk Percutaneous Coronary Interventions

08/01/2008

In this issue of the Journal, Biswajit Kar, et al. report their initial experience using the TandemHeart Percutaneous Ventricular Assist Device (CardiacAssist, Inc., Pittsburgh, Pennsylvania) in patients who were undergoing a high-risk...

In this issue of the Journal,...

08/01/2008

Journal of Invasive Cardiology

Case Report

A Comprehensive Evidence-Based Decision Algorithm for Assisting Clinicians and Patients With Stable Ischemic Heart Disease in Selecting Revascularization Strategy in Multivessel Disease

04/26/2018

William S. Weintraub , MD, FACC;

Lloyd W. Klein , MD;

We propose an evidenced-based algorithm for the optimal revascularization of multivessel, non-ACS presentations.

We propose an evidenced-based...

04/26/2018

Journal of Invasive Cardiology

Review

A Comprehensive Evidence-Based Decision Algorithm for Assisting Clinicians and Patients With Stable Ischemic Heart Disease in Selecting Revascularization Strategy in Multivessel Disease

08/02/2018

Lloyd W. Klein , MD;

William S. Weintraub , MD, FACC;

The adoption and consistent use of evidence-based information, rather than reliance on subjective judgment and its inherent biases, requires considerable effort and tools that are easily utilized in the clinical environment.

The adoption and consistent use...

08/02/2018

Cath Lab Digest

Updated Risk Adjustment Mortality Model Using the Complete 1.1 Dataset from the American College of Cardiology National Cardiova

08/01/2008

Leslee J. Shaw , PhD;

Peter C. Block , MD;

William S. Weintraub , MD, FACC;

Charles R. McKay , MD;

Ralph G. Brindis , MD, MPH, FACC;

Kathleen Hewitt , MSN, RN, CPHQ;

Lloyd W. Klein , MD;

Ronald J. Krone , MD;

Vernon Anderson , MD;

Richard E. Shaw , PhD, FACC;

The use of risk adjustment methodology to account for patient differences in treatment outcomes is imperative to legitimately compare the results of institutions performing cardiovascular intervention. Mortality has been the most widely used...

The use of risk adjustment...

08/01/2008

Journal of Invasive Cardiology

Methods for the Economic and Quality of Life Supplement to the Cilostazol for RESTenosis (CREST) Trial

08/01/2008

William S. Weintraub , MD, FACC;

Jovonne Foster , MS;

Kar Parker , BS;

Zefeng Zhang , MD, PhD;

Paul Kolm , PhD;

John S. Douglas Jr., MD;

Edmund R. Becker , PhD;

Steven D. Culler , PhD;

ABSTRACT: Objective: To determine economic and quality of life outcomes for the Cilostazol for RESTenosis (CREST) trial, which is investigating the efficacy of cilostazol vs placebo in preventing post-stent restenosis. Design: CREST is a...

ABSTRACT: Objective: To...

08/01/2008

Journal of Invasive Cardiology

Risk of Local Adverse Events Following Cardiac Catheterization by Hemostasis Device Use and Gender

08/01/2008

Dale R. Tavris , MD, MPH;

Richard E. Shaw , PhD, FACC;

Beverly Albrecht-Gallauresi , RN, MPH;

Ralph G. Brindis , MD, MPH, FACC;

Ba Lin , MD;

Suzanne E. Rich , RN, MA;

Kathleen Hewitt , MSN, RN, CPHQ;

William S. Weintraub , MD, FACC;

Reports of serious injuries and deaths associated with the use of hemostasis devices1 to the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) provided the impetus for this study. These devices are...

Reports of serious injuries and...

08/01/2008

Journal of Invasive Cardiology

Risk of Local Adverse Events following Cardiac Catheterization
by Hemostasis Device Use ‚Äî Phase II

08/01/2008

William S. Weintraub , MD, FACC;

Richard E. Shaw , PhD, FACC;

Dale R. Tavris , MD, MPH;

Syamal Dey , MS, PhD;

Beverly Albrecht-Gallauresi , RN, MPH;

Ralph G. Brindis , MD, MPH, FACC;

Kristi Mitchel , MPH;

Reports to the Center for Devices and Radiological Health (CDRH) of the FDA regarding serious injuries and deaths associated with the use of vascular hemostasis devices1 provided the impetus for this study. These devices are used primarily to...

Reports to the Center for...

08/01/2008

Journal of Invasive Cardiology

Impact of Diabetes on Five-Year Outcomes after Vein Graft Interventions Performed Prior to the Drug-Eluting Stent Era

08/01/2008

Salman Ashfaq , MD;

Ziyad Ghazzal , MD;

Douglas C. Morris , MD;

Emir Veledar , MD;

William S. Weintraub , MD, FACC;

John S. Douglas Jr., MD;

While an increasing proportion of the grafts used during coronary artery bypass (CABG) procedures are arterial, the majority of grafts implanted at most centers have been and continue to be saphenous vein grafts. On long-term follow up, up to...

While an increasing proportion...

08/01/2008

Journal of Invasive Cardiology